# (DRAFT) Establishing Qualification Processes for Agile Pharmaceutical Manufacturing (EQUIP-A-Pharma)

Canonical: https://abierto.us/opportunities/darpaps2411

- Solicitation number: DARPA-PS-24-11
- Notice type: Presolicitation
- Status: Closed. Deadline was January 25, 2024
- Department: Department of Defense
- Agency: Defense Advanced Research Projects Agency
- Contracting office: Def Advanced Research Projects Agcy (HR0011)
- NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Product or service code: AC12 National Defense R&D Services; Department Of Defense - Military; Applied Research
- First posted: January 8, 2024
- Last posted: January 24, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/d880618ab97a45bf836db0f8ee575fdc/view

## Description

(DRAFT) The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative approaches to address challenges in qualifying drug products produced in an agile pharmaceutical manufacturing platform. EQUIP-A-Pharma will aim to develop the technology and process models to demonstrate real-time qualification of multiple drug products produced by reprogramming or reconfiguring the manufacturing platform and inform the creation of a future regulatory framework for agile pharmaceutical manufacturing.

## Publications

- January 8, 2024: Presolicitation, due February 28, 2024. Notice 4ad34752d4cc466fb9ac67e0c5c31941. https://sam.gov/workspace/contract/opp/4ad34752d4cc466fb9ac67e0c5c31941/view
- January 24, 2024: Presolicitation, due January 25, 2024. Notice d880618ab97a45bf836db0f8ee575fdc. https://sam.gov/workspace/contract/opp/d880618ab97a45bf836db0f8ee575fdc/view

## Points of contact

- BAA Coordinator, EQUIP@darpa.mil

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/darpaps2411.